Storia in 4 fonti

SK Bioscience to license vaccine technology to Colombia - The Korea Times

SK Bioscience will license its vaccine technology to Colombia’s state-owned pharmaceutical firm VECOL and cooperate in establishing a local manufac...

Raccontata da

elespectador.com

koreatimes.co.kr

koreaherald.com

pharmaceutical-technology.com

Confronto fonti

4 prospettive sulla stessa storia

AI · summaries

koreatimes.co.krStai leggendo1 g fa

SK Bioscience to license vaccine technology to Colombia - The Korea Times

SK Bioscience signed a technology licensing agreement with Colombia's VECOL, including 600,000 doses of SKYVaricella ordered for 2026, backed by a $260M national vaccine localization program over 10 years. The deal signals a growing market for WHO-prequalified vaccine manufacturers willing to commit to in-country tech transfer — a model increasingly required for public health procurement across emerging markets.

originale

koreaherald.com1 g fa

SK Bioscience joins Colombia’s vaccine localization project

SK Bioscience said Tuesday it signed an agreement with VECOL, a state-run producer of animal health and biotechnology products in Colombia, for vaccine technolo

Leggi questa versione → originale

pharmaceutical-technology.com12 h fa

SK bioscience and VECOL partner on Colombia vaccine manufacturing initiative

SK bioscience has signed a vaccine technology transfer and manufacturing deal with VECOL, becoming part of Colombia’s $260m vaccine localisation initiative.

Leggi questa versione → originale

elespectador.com2 g fa

Gobierno firma acuerdo con empresa surcoreana para avanzar en producción de vacunas humanas

Vecol y SK bioscience anunciaron la firma de un acuerdo para avanzar en producción de vacunas humanas en Colombia.

Leggi questa versione → originale

Timeline cronologica

lunedì 25 maggio 2026·elespectador.com
Gobierno firma acuerdo con empresa surcoreana para avanzar en producción de vacunas humanas
Vecol y SK bioscience anunciaron la firma de un acuerdo para avanzar en producción de vacunas humanas en Colombia.
martedì 26 maggio 2026·koreatimes.co.kr
SK Bioscience to license vaccine technology to Colombia - The Korea Times
SK Bioscience will license its vaccine technology to Colombia’s state-owned pharmaceutical firm VECOL and cooperate in establishing a local manufac...
martedì 26 maggio 2026·koreaherald.com
SK Bioscience joins Colombia’s vaccine localization project
SK Bioscience said Tuesday it signed an agreement with VECOL, a state-run producer of animal health and biotechnology products in Colombia, for vaccine technolo
mercoledì 27 maggio 2026·pharmaceutical-technology.com
SK bioscience and VECOL partner on Colombia vaccine manufacturing initiative
SK bioscience has signed a vaccine technology transfer and manufacturing deal with VECOL, becoming part of Colombia’s $260m vaccine localisation initiative.